TT5
Phase 1Small molecule
TT5 is one of 7 small molecule programs targeting Surgical. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
7 competitors in Surgical
#DrugCompanyPhaseTrials
1Naropin
FFresenius Kabi USA, LLC
Phase 2
Xyrem
Jazz PharmaceuticalsPreclinical
TLC590
TTLC Biopharmaceuticals, Inc.
Phase 2
Platelet Rich Fibrin
GGovernment Dental College and Research Institute, Bangalore
Preclinical
TT5
TTafalgie Therapeutics
Phase 1
Sodium Hypochlorite Gel Application
UUniversity of Messina
Preclinical
TISSEEL
UUniversity Hospital, Ghent
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for TT5. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- TTafalgie Therapeutics